Source: Paris 2018 - Educational material
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
PG13 Challenges in the treatment of tuberculosis. Paris 2018 - Educational material

Member's Comments

No comment yet.

Related content which might interest you: Management and treatment of multidrug-resistant tuberculosis Source: International Congress 2019 – Tuberculosis: latest advances and challenges in patient management Year: 2019 Monitoring during and after tuberculosis treatment Source: Eur Respir Monogr 2018; 82: 308-325 Year: 2018 Challenges in childhood tuberculosis Source: Eur Respir Monogr 2018; 82: 234-262 Year: 2018 Challenges and perspectives for improved management of HIV/Mycobacterium tuberculosis co-infection Source: Eur Respir J 2010; 36: 1242-1247 Year: 2010 Evaluation of treatment outcomes for multidrug-resistant tuberculosis Source: Eur Respir J 2001; 18: Suppl. 33, 312s Year: 2001 Evaluation of failures treated with linezolid-containing regimen for extensively drug-resistant tuberculosis (XDR-TB) Source: International Congress 2015 – TB treatment: new drugs and drug resistance Year: 2015 The efficiency of surgical treatment for multidrug-resistant pulmonary and pleural tuberculosis Source: International Congress 2016 – Surgical strategy for complex diseases Year: 2016 Management of multidrug-resistant tuberculosis and patients in retreatment Source: Eur Respir J 2005; 25: 928-936 Year: 2005 Experience of skin test application using tuberculosis recombinant allergen (Diaskintest) in tuberculosis diagnostics of children Source: International Congress 2015 – Biomarkers in TB: immunology and physiology Year: 2015 Treatment of drug-susceptible and drug-resistant tuberculosis Source: Eur Respir Monogr 2018; 82: 152-178 Year: 2018 Experience in the use of Bedakville in the therapy of multidrug-resistant tuberculosis and HIV infection. Source: International Congress 2018 – Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis Year: 2018 Effectiveness and safety of imipenem/clavulanate- versus meropenem/clavulanate-containing regimens in the treatment of multidrug resistant tuberculosis Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments Year: 2016 Side effects of chemical preparations in patients with drug-resistant pulmonary tuberculosis Source: International Congress 2015 – Healthcare organisation and appropriateness in lung disorders Year: 2015 Comparision of line probe assay and conventional methos for detection of mycobacteria other than tuberculosis (MOTT) strains from patients suferring from pulmonary tuberculosis Source: International Congress 2016 – Non-tuberculous mycobacteria: HIV-TB co-infection and adenosine deaminase (ADA) Year: 2016 Successful treatment of multidrug-resistant tuberculosis through a binational consortium Source: Annual Congress 2011 - Multidrug-resistant tuberculosis Year: 2011 A new era for treatment of drug-resistant tuberculosis Source: Eur Respir J, 52 (4) 1801350; 10.1183/13993003.01350-2018 Year: 2018 Properties of cultures of M. tuberculosis isolated from the surfaces of objects TB facilities Source: Annual Congress 2013 –Diagnostic features of tuberculosis II Year: 2013 Differentiated approaches for chemoprophylaxis of tuberculosis in prisons Source: Eur Respir J 2002; 20: Suppl. 38, 548s Year: 2002 Experience of the bronchial treatment of tuberculosis of the bronchos in the conditions of the tuberculosis epidemic in Ukraine Source: Annual Congress 2007 - Therapeutic bronchoscopy Year: 2007